M. Kyle Jensen,
MD
No Rating Available?
0
out of
5
Patient Rating
In order to provide our patients and visitors with the most accurate and useful information, we only post physician satisfaction data when a physician has received a minimum of 30 returned surveys. For this provider, we have not yet received the
minimum.
Languages Spoken: English, Spanish
Dr. Jensen received his medical degree from the University of Utah School of Medicine, completed a pediatric residency at Primary Children’s Hospital, followed by a Pediatric Gastroenterology, Hepatology and Nutrition Fellowship at the Children’s Hospital of Wisconsin in Milwaukee, Wisconsin. He then completed an Advanced Pediatric Hepatology and Transplant Hepatology Fellowship at Cincinnati Children’s Hospital Medical Center in Cincinnati, Ohio. Dr. Jensen is board-certified in Pediatrics, Pediatric Gastroenterology, and Pediatric Transplant Hepatology.
He is currently an Associate Professor of Pediatrics at the University of Utah and is in the Division of Pediatric Gastroenterology at Primary Children´s Hospital. His primary clinical interests are in pediatric liver diseases including caring for children who need liver transplantation.
Dr. Jensen’s research interests include pediatric liver diseases as well as outcomes and quality research in transplantation and pediatric gastroenterology, with an emphasis in epidemiology.
Clinical Locations
Primary Children's Hospital Outpatient Services at Riverton
801-213-3599
Board Certification and Academic Information
| Academic Departments | Pediatrics
-
Associate Professor (Clinical) |
| Academic Divisions | Pediatric Gastroenterology |
| Board Certification | American Board of Pediatrics (Pediatrics) American Board of Pediatrics (Sub: Pediatric Gastroenterology) Pediatric Transplant Hepatolgoy - Subspecialty |
Dr. Jensen received his medical degree from the University of Utah School of Medicine, completed a pediatric residency at Primary Children’s Hospital, followed by a Pediatric Gastroenterology, Hepatology and Nutrition Fellowship at the Children’s Hospital of Wisconsin in Milwaukee, Wisconsin. He then completed an Advanced Pediatric Hepatology and Transplant Hepatology Fellowship at Cincinnati Children’s Hospital Medical Center in Cincinnati, Ohio. Dr. Jensen is board-certified in Pediatrics, Pediatric Gastroenterology, and Pediatric Transplant Hepatology.
He is currently an Associate Professor of Pediatrics at the University of Utah and is in the Division of Pediatric Gastroenterology at Primary Children´s Hospital. His primary clinical interests are in pediatric liver diseases including caring for children who need liver transplantation.
Dr. Jensen’s research interests include pediatric liver diseases as well as outcomes and quality research in transplantation and pediatric gastroenterology, with an emphasis in epidemiology.
Academic Locations
Eccles Primary Children’s Outpatient Services Building
801-213-3599
Board Certification and Academic Information
| Academic Departments | Pediatrics
-
Associate Professor (Clinical) |
| Academic Divisions | Pediatric Gastroenterology |
| Board Certification | American Board of Pediatrics (Pediatrics) American Board of Pediatrics (Sub: Pediatric Gastroenterology) Pediatric Transplant Hepatolgoy - Subspecialty |
Research Interests
- Pediatric Hepatology
- Epidemiology of Childhood Intestinal and Liver Diseases
- Liver Transplantation
Education History
| Fellowship | Cincinnati Children’s Hospital & Medical Center Advanced Hepatology Fellow |
| Graduate Training | Medical College of Wisconsin Epidemiology/Clinical and Translational Science M.S. |
| Fellowship | Medical College of Wisconsin/Children’s Hospital of Wisconsin Pediatric Gastroenterology Fellow |
| Residency | University of Utah, Primary Children’s Medical Center Pediatrics Resident |
| Professional Medical | University of Utah School of Medicine Medicine M.D. |
| Undergraduate | University of Wyoming B.S. |
Selected Publications - Journal Articles
Journal Article
- Deneau MR, Mack C, Perito ER, Ricciuto A, Valentino PL, Amin M, Amir AZ, Aumar M, Auth M, Broderick A, DiGuglielmo M, Draijer LG, Tavares Fagundes ED, El-Matary W, Ferrari F, Furuya KN, Gupta N, Hochberg JT, Homan M, Horslen S, Iorio R, Jensen MK, Jonas MM, Kamath BM, Kerkar N, Kim KM, Kolho KL, Koot BG, Laborda TJ, Lee CK, Loomes KM, Martinez M, Miethke A, Miloh T, Mogul D, Mohammed S, Mohan P, Moroz S, Ovchinsky N, Palle S, Papadopoulou A, Rao G, Rodrigues Ferreira A, Sathya P, Schwarz KB, Shah U, Shteyer E, Singh R, Smolka V, Soufi N, Tanaka A, Varier R, Vitola B, Woynarowski M, Zerofsky M, Zizzo A, Guthery SL (2020). The Sclerosing Cholangitis Outcomes in Pediatrics (SCOPE) index: a prognostic tool for children. (Epub ahead of print) Hepatology.
- Ermarth A, Jensen MK (2020). A North American Serologic-based Celiac Disease Diagnosis: If Not Now, Then When? J Pediatr Gastroenterol Nutr, 70(5), e107.
- Jaramillo C, Guthery SL, Lowichik A, Stoddard G, Kim T, Li Y, Jensen MK (2019). Quantitative Liver Fibrosis Using Collagen Hybridizing Peptide to Predict Native Liver Survival in Biliary Atresia: A Pilot Study. J Pediatr Gastroenterol Nutr, 70(1), 87-92.
- Deneau MR, Valentino PL, Mack C, Alqoaer K, Amin M, Amir AZ, Aumar M, Auth M, Broderick A, DiGuglielmo M, Draijer LG, El-Matary W, Ferrari F, Furuya KN, Gottrand F, Gupta N, Homan M, Jensen MK, Kamath BM, Kim KM, Kolho KL, Koot B, Iorio R, Martinez M, Miloh T, Mohan P, Palle S, Papadopoulou A, Ricciuto A, Saubermann L, Sathya P, Shteyer E, Smolka V, Tanaka A, Varier R, Venkat V, Vitola B, Woynarowski M, Guthery S (2019). Assessing the Validity of Adult-derived Prognostic Models for Primary Sclerosing Cholangitis Outcomes in Children. J Pediatr Gastroenterol Nutr, 70(1), e12-e17.
- Deneau M, Perito E, Ricciuto A, Gupta N, Kamath BM, Palle S, Vitola B, Smolka V, Ferrari F, Amir AZ, Miloh T, Papadopoulou A, Mohan P, Mack C, Kolho KL, Iorio R, El-Matary W, Venkat V, Chan A, Saubermann L, Valentino PL, Shah U, Miethke A, Lin H, Jensen MK (2019). Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis: Predictors of Gamma Glutamyltransferase Normalization and Favorable Clinical Course. J Pediatr, 209, 92-96.e1.
- Nicholson MR, Mitchell PD, Alexander E, Ballal S, Bartlett M, Becker P, Davidovics Z, Docktor M, Dole M, Felix G, Gisser J, Hourigan SK, Jensen MK, Kaplan JL, Kelsen J, Kennedy M, Khanna S, Knackstedt E, Leier M, Lewis J, Lodarek A, Michail S, Oliva-Hemker M, Patton T, Queliza K, Russell GH, Singh N, Solomon A, Suskind DL, Werlin S, Kellermayer R, Kahn SA (2019). Efficacy of Fecal Microbiota Transplantation for Clostridium difficile Infection in Children. (Epub ahead of print) Clin Gastroenterol Hepatol.
- Laborda TJ, Jensen MK, Kavan M, Deneau M (2019). Treatment of primary sclerosing cholangitis in children. World J Hepatol, 11(1), 19-36.
- Davidovics, Zev H, Michail, Sonia, Nicholson, Maribeth R, Kociolek, Larry K, Pai, Nikhil, Hansen, Richard, Schwerd, Tobias, Maspons, Aldo, Shamir, Raanan, Szajewska, Hania, Thapar, Nikhil, de Meij, Tim, Mosca, Alexis, Vandenplas, Yvan, Kahn, Stacy A, Kellermayer, Richard, and the FMT Special Interest Group of the North American Society of Pediatric Gastroenterology Hepatology, Nutrition, the European Society for Pediatric Gastroenterology (12/11/2018). Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection and Other Conditions in Children: A Joint Position Paper From the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr.
- Barfuss S, Jensen MK, Knackstedt E, Molina K, Lal A (09/2018). Cardiac allograft vasculopathy following fecal microbiota transplantation for recurrent C. difficile infectionJournal: Article ID: TID12983Article DOI: 10.1111/tid.12983Internal Article ID: 15939785. Transpl Infect Dis.
- Deneau MR, Mack C, Abdou R, Amin M, Amir A, Auth M, Bazerbachi F, Marie Broderick A, Chan A, DiGuglielmo M, El-Matary W, El-Youssef M, Ferrari F, Furuya KN, Gottrand F, Gupta N, Homan M, Jensen MK, Kamath BM, Mo Kim K, Kolho KL, Konidari A, Koot B, Iorio R, Martinez M, Mohan P, Palle S, Papadopoulou A, Ricciuto A, Saubermann L, Sathya P, Shteyer E, Smolka V, Tanaka A, Valentino PL, Varier R, Venkat V, Vitola B, Vos MB, Woynarowski M, Yap J, Miloh T (2018). Gamma Glutamyltransferase Reduction Is Associated With Favorable Outcomes in Pediatric Primary Sclerosing Cholangitis. Hepatol Commun, 2(11), 1369-1378.
- Deneau MR, El-Matary W, Valentino PL, Abdou R, Alqoaer K, Amin M, Amir AZ, Auth M, Bazerbachi F, Broderick A, Chan A, Cotter J, Doan S, El-Youssef M, Ferrari F, Furuya KN, Gottrand M, Gottrand F, Gupta N, Homan M, Kamath BM, Kim KM, Kolho KL, Konidari A, Koot B, Iorio R, Ledder O, Mack C, Martinez M, Miloh T, Mohan P, OCathain N, Papadopoulou A, Ricciuto A, Saubermann L, Sathya P, Shteyer E, Smolka V, Tanaka A, Varier R, Venkat V, Vitola B, Vos MB, Woynarowski M, Yap J, Jensen MK (2017). The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration. Hepatology, 66(2), 518-527.
- Elizabeth Parsons C, Nelson R, Book LS, Kyle Jensen M (2014). Renal replacement therapy in infants and children with hepatorenal syndrome awaiting liver transplantation: a case-control study. Liver Transpl, 20(12), 1468-74.
- Deneau M, Book LS, Guthery SL, Jensen MK (2014). Outcome after discontinuation of immunosuppression in children with autoimmune hepatitis: a population-based study. J Pediatr, 164(4), 714-719.e2.
- Deneau M, Jensen MK, Holmen J, Williams MS, Book LS, Guthery SL (October 2013). Primary Sclerosing Cholangitis, Autoimmune Hepatitis and Overlap in Utah Children: Epidemiology and Natural History. Hepatology.
- Deneau M, Jensen MK, Holmen J, Williams MS, Book LS, Guthery SL (2013). Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in Utah children: epidemiology and natural history. Hepatology, 58(4), 1392-400.
- Jensen MK, Campbell KM, Alonso MH, Nathan JD, Ryckman FC, Tiao GM (2013). Management and long-term consequences of portal vein thrombosis after liver transplantation in children. Liver Transpl, 19(3), 315-21.
- Jensen MK, Biank VF, Moe DC, Simpson PM, Li SH, Telega GW (2012). HIDA, percutaneous transhepatic cholecysto-cholangiography and liver biopsy in infants with persistent jaundice: can a combination of PTCC and liver biopsy reduce unnecessary laparotomy? Pediatr Radiol, 42(1), 32-9.
- Jensen MK, Tipnis NA, Bajorunaite R, Sheth MK, Sato TT, Noel RJ (2010). Capsule endoscopy performed across the pediatric age range: indications, incomplete studies, and utility in management of inflammatory bowel disease. Gastrointest Endosc, 72(1), 95-102.
Book Chapter
- Jensen MK, Balistreri WF (2015). Viral Hepatitis. In Robert Kliegman, Bonita Stanton, Richard Behrman, Joseph St. Geme and Nina Schor (Eds.), Nelson Textbook of Pediatrics (20, pp. 1942-53). Philadelpha: Elsevier.
- Sampert C, Jensen MK (2014). Esophageal Varices. In Pohl / Jolley / Gelfond (Ed.), Pediatric Gastroenterology – A Color Handbook (1st). London: Manson Publishing.
- Jensen MK, Alonso MA, Nathan JD, Ryckman FC, Tiao G, Balistreri WF (2014). Liver Transplantation in Children: Indications and Surgical Aspects. In Suchy, Sokol, Balistreri WF (Eds.), Liver disease in Children (4th, pp. 760-772). Cambridge, UK: Cambridge University Press.
- Jensen MK, Telega G (2008). Infections of the Liver and Biliary Tract. In Rudolph, Lister, Gershon, First, Rudolph (Eds.), Rudolph’s Pediatrics (22nd). New York, New York: McGraw-Hill.
Abstract
- Pachal P, Kahn S, Zellmer C, Kassam Z, Osman M, Allegretti J, Seng M, Budree, AB, NASPGHAN FMT Special Interest Group (11/26/2018). Scaling Pediatric Access to Fecal Microbiota Transplantation in the United States: A Time-Series Geospatial Analysis. [Abstract]. Open Forum Infectious Disease, 5(suppl_1), 197.
Global Impact
Service
| 11/30/2016 | Working Group Member | In addition to serving as the local/regional medical directof of fecal microbiota transplant (FMT) at Primary Children's Hospital. I have represented us in the NASPGHAN FMT special interest group collaborating clinical data for a large, multicenter clinical collaboration to evaluate safety and efficacy of FMT in the pediatric group. PCH is one of the largest contributors to this large collaboration. | Canada |
| 09/09/2014 | Member | QI and Research Committees | Canada |